Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Cumberland Pharma Out-licenses Products to Harbin Gloria

publication date: Feb 29, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Cumberland Pharma of the US has out-licensed the China rights for two of its drugs to Harbin Gloria Pharma. The two drugs are Acetadote, an injectable drug used to treat acetaminophen overdose, and Caldolor, an injectible form of ibuprofen used to treat pain and fever in a hospital. Harbin Gloria will be responsible for obtaining SFDA approval for the two products, and it will also assume marketing and distribution duties. More details....

Stock Symbols: (NSDQ: CPIX) (SHE: 002437)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at this event:
 
 
Hope to see you there!
 
ChinaBio® Events
 
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors